Commercialisation firm PureTech raises an additional $50m to bring its October 2014 fundraising up to $107m.

US-based commercialisation firm PureTech has secured an additional $50m, topping up its October 2014 $57m round to $107m. Investors were not disclosed.

Founded in 2001, the company is a hybrid between a venture capital firm, an incubator, and a technology transfer office. PureTech is looking to bring together intellectual property from different sources to create companies, and is focused on the life sciences sector.

Daphne Zohar, founder and CEO of PureTech, said: “We bring together experts — people who have thought deeply about a problem, and people who have never thought about the problem. In order to compensate people, we structure each project as separate companies, so they can get equity in that project. In most cases, we’re the majority owner of that company.”